CDER/CBER s Top 7 CDISC Standards Issues



Similar documents
USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE

Lessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014

SDTM AND ADaM: HANDS-ON SOLUTIONS

New features in SDTM-ETL v SDTM-ETL TM. New Features in version 1.2

Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program

Implementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland

Einführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung

A Macro to Create Data Definition Documents

How to easily convert clinical data to CDISC SDTM

Business & Decision Life Sciences What s new in ADaM

Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission

STUDY DATA TECHNICAL CONFORMANCE GUIDE

STUDY DATA TECHNICAL CONFORMANCE GUIDE

PharmaSUG2010 HW06. Insights into ADaM. Matthew Becker, PharmaNet, Cary, NC, United States

Implementing the CDISC standards into an existing CDMS

Smart Dataset-XML Viewer: Web Services

Use of standards: can we really be analysis ready?

A Brief Introduc/on to CDISC SDTM and Data Mapping

Copyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS

Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide

PharmaSUG2010 Paper CD04 CD04

Using the SAS XML Mapper and ODS PDF to create a PDF representation of the define.xml (that can be printed)

ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA

PhUSE Paper CD13

How to build ADaM from SDTM: A real case study

STUDY DATA TECHNICAL CONFORMANCE GUIDE

PharmaSUG Paper DS07

The CDISC/FDA Integrated Data Pilot: A Case. Support an Integrated Review

Managing Custom Data Standards in SAS Clinical Data Integration

SDTM-ETL TM. The user-friendly ODM SDTM Mapping software package. Transforming operational clinical data into SDTM datasets is not an easy process.

ABSTRACT On October 1st, 2008, CDASH released the first 16 common CRF streams (or domains) for use by the Pharmaceutical Industry.

Pharmaceutical Applications

SDTM, ADaM and define.xml with OpenCDISC Matt Becker, PharmaNet/i3, Cary, NC

Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies

Business & Decision Life Sciences

Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process

Automate Data Integration Processes for Pharmaceutical Data Warehouse

Common Misunderstandings about ADaM Implementation

Clinical Trial Data Integration: The Strategy, Benefits, and Logistics of Integrating Across a Compound

SDTM Validation: Methodologies and Tools

Use of Metadata to Automate Data Flow and Reporting. Gregory Steffens Novartis PhUSE 13 June 2012

Current Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other

SDTM Validation Rules in XQuery

Providing Regulatory Submissions In Electronic Format Standardized Study Data

ABSTRACT INTRODUCTION THE MAPPING FILE GENERAL INFORMATION

Robust tools to Create Define.xml v2.0 based submission components for SDTM, ADAM & SEND Vineet Jain, Independent Consultant

Understanding CDISC Basics

Vasanth Kumar Kunitala et al, SPJTS.1.(2), ISSN

The ADaM Solutions to Non-endpoints Analyses

CREATING SV AND SE FIRST Henry B. Winsor, WinsorWorks, Limited, San Mateo, CA Mario Widel, Genentech, Inc., South San Francisco, CA

CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co

Practical application of SAS Clinical Data Integration Server for conversion to SDTM data

Analysis Data Model: Version 2.0

ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC

A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA

Sanofi-Aventis Experience Submitting SDTM & Janus Compliant Datasets* SDTM Validation Tools - Needs and Requirements

Metadata and ADaM.

Data Standards Strategy. Version: 1.0

PharmaSUG Paper DS15

SAS CLINICAL TRAINING

SDTM-ETL 3.1 New Features

Guidance for Industry

Strategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets

Analysis Data Model (ADaM)

CDISC standards and data management The essential elements for Advanced Review with Electronic Data

Trials and Tribulations of SDTM Trial Design

CDISC Asthma Therapeutic Area Data Standards User Guide Yes, it is interesting! Paul Terrill

PharmaSUG 2015 Paper SS10-SAS

PK IN DRUG DEVELOPMENT. CDISC management of PK data. Matteo Rossini Milan, 9 February 2010

ProjectTrackIt: Automate your project using SAS

Analysis Data Model (ADaM) Implementation Guide

Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Alcohol Use Disorder Identification Test Self-Report Version (AUDIT-SR)

Building and Customizing a CDISC Compliance and Data Quality Application Wayne Zhong, Accretion Softworks, Chester Springs, PA

Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)

Synergizing global best practices in the CRO industry

Package R4CDISC. September 5, 2015

Implementing CDASH Standards Into Data Collection and Database Design. Robert Stemplinger ICON Clinical Research

Note: See 7.7 Representations and Warranties, Limitations of Liability, and Disclaimer.

Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development organization like these:

The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions

SAS CLINICAL STANDARDS TOOKIT

How to Use SDTM Definition and ADaM Specifications Documents. to Facilitate SAS Programming

Guidance for Industry

Clinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms

WHITE PAPER. CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. SUCCESSFUL TRIALS THROUGH PROVEN SOLUTIONS

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG Paper PH-07

CDISC Journal. Regulatory Submissions for Medical Devices and Diagnostics: The Basics

Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL

Guidelines on the Nonconformity Grading and Exchange Form MDSAP AU G

Janus Clinical Trials Repository (CTR) An Update

PhUSE Metadata Management Project

CDISC SDTM/ADaM Pilot Project 1 Project Report

UTILIZING CDISC STANDARDS TO DRIVE EFFICIENCIES WITH OPENCLINICA Mark Wheeldon CEO, Formedix Boston June 21, 2013

PhUSE Annual Meeting, London 2014

Development of CDISC Tuberculosis Data Standards

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management

Transcription:

CDER/CBER s Top 7 CDISC Standards Issues Dhananjay Chhatre, MS, RAC edata Management Solutions Team Office of Business Informatics CDER, U.S. FDA Amy Malla Review Management CBER, U.S. FDA

Background ~ 30% of unique NDAs received by CDER in 2011 submitted CDISC/SDTM data ~ 20% of the BLA s received by CBER in 2011 submitted CDISC/SDTM data Although standardization has allowed for use of additional data analysis tools, issues with either the implementation of the standard, or the standard itself, have proven to be inhibitive to the regulatory review process

Top 6 Issues 1 Waste of Space 2 Extras 3 Validation Errors 4 Extended Codelists 5 ISO Dates 6 Traceability 7 Inadequate Documentation

1. Waste of Space edata team performed research on cause of large dataset sizes Randomly selected 20 studies (432 datasets) Identified correlation between dataset sizes and allotted column variable length Columns lengths were being padded i.e. actual length = 8, allotted length = 200 Impact on dataset size compounded by large number of rows

1. Waste of Space Reduced to the width needed Variable Name Variable Type Previous Variable Length Modified Variable Length DOMAIN Character 2 2 LBBLFL Character 2 2 LBCAT Character 200 20 LBDTC Character 50 20 LBNRIND Character 8 8 LBORNRHI Character 200 10 LBORNRLO Character 200 10 LBORRES Character 200 15 LBORRESU Character 200 10 LBREFID Character 200 15 LBSEQ Numeric 8 8 LBSPID Character 200 5 LBSTAT Character 8 8 LBSTNRHI Numeric 8 8 LBSTNRLO Numeric 8 8 LBSTRESC Character 200 15 Totals bytes used ~ 1/10 the size LBSTRESN Numeric 8 8 LBSTRESU Character 200 10 LBTEST Character 200 30 LBTESTCD Character 8 8 STUDYID Character 200 10 USUBJID Character 200 20 VISIT Character 200 25 VISITNUM Numeric 8 8 Total 2718 283

1. Waste of Space Observed 70% file size reduction, on average, across 432 datasets Collaborated with Phrma group 14 participants (15 studies, 545 datasets) 68% file size reduction, on average But why is this phenomenon being seen in CDISC/SDTM datasets, and not legacy data?

1. Waste of Space SAS transport version 5 specifications allocate space within every row and column (cell) based on the overall column s defined variable length In the CDISC IG, an example references a column length of 200 It appears this example was taken to heart by industry Added wording in CDER Common Data Standards Issues Document and worked with CDISC to add similar wording in the recent update to clarify that column lengths should not be set to an arbitrary limit of 200 This requirement text will also be added to the Data Standards Specifications next revision (in progress)

2. Extras (Domains, Variables, SUPPQUAL) CDISC IGs (SDTM and ADaM) specify standard domains and variables, but allow sponsor to create their own domains and variables If no existing model seems appropriate SUPP- domains contain unnecessary information Use common sense and discuss with review team on whether all information in supp- datasets are necessary. For example, do not create a SUPPQUAL domain just to include the initials of the subject.

2. Extras (Domains, Variables, SUPPQUAL) The findings, events and interventions domain classes list variables that are allowable. Many of these variables are not in the published parent domain but instead placed in the SUPPQUAL. In compliance with the standard, the variables should be added to the parent domain and eliminated from SUPPQUAL If important variables (support key analyses) are placed in SUPPQUAL, discuss with the review team

3. Validation Errors CDER and CBER currently use OpenCDISC v1.2 Validation process results in error log -> read it! Errors and warnings that CAN be fixed, SHOULD be fixed Some errors/warnings will inherently exist because of your study design i.e. no baseline result, no exposure record Others won t Don t simply address and dismiss these errors in a Reviewer s Guide

3. Validation Errors Common Errors a) Codelist mis-match for extensible codelists b) End date is prior to start date c) Required and expected variables should be present in the dataset d) Variable labels in the dataset should match CDISC naming conventions e) AE set to serious but no qualifier exists that has been set to Y

4. Extended Codelists Submissions include codelists where variable values are not included in the codelist Incorrect define.xml

4. Extended Codelists Type Message N Rows Error Invalid ISO 8601 value 384 Informa The source data for SV is missing an 1 Warning Value for VSTEST not found in VSTEST 2840 Example of bad D efine.xml causing V S.T EST Codelist errors (CT 0054). < Item D e f OID ="VS.VSTEST CD " Nam e ="VSTESTC D " Da ta Type ="te x t " Leng th ="8 " O rig in =" A s s ign ed " Co m m e n t =" " de f : L a b el="vit a l Sig n s T e s t Sh o rt N a m e "> < C od elis t R ef Co d e L i s to I D =" VS_ VST EST C D _ C D "> < / C o de Lis t R e f > < d e f: V a lu e L is tr ef Va l u e L is t O ID ="VS. VS T E ST C D ~ Va l u e "> < / de f: V a lu e L is t R ef > </ Ite m D e f> < It em D e f OID ="VS.VSTEST " Nam e ="VSTEST " Da ta Type ="te x t " Le ng th =" 40 " O rig in =" A s s ign ed " Co m m e n t =" " de f : L a b el="vit a l Sig n s T e s t N a m e "> < C od elis t R ef Co d e L i s </ Ite m D e f> to I D =" VS_ VST EST _ C D " ></Co d e L i s tre f>

4. Extended Codelists Not in codelist 2/2/2012 14

4. Extended Codelists Fixed with one xml line edit 2/2/2012 15

5. ISO Dates SDTM IG allows for partial dates Date issues can arise from invalid ISO 8601 partial dates Start date and end date should contain similar length and characteristics Type Message N Rows Error Informati on Warning Invalid ISO 8601 value The source data for SV is missing an Value for VSTEST not found in VSTEST 384 1 2840 Common Problem

5. ISO Dates YYYY-MM-DDThh:mm:ss (i.e. 2001-12-26T07:10:15) Includes time element Only day (no time) Results in Invalid ISO 8601 value error Since time indicated in one column, standard time of midnight is assumed for 2nd, which occurs before start date, causing the error Clarification needs to occur in CDISC IGs regarding when to input times and when to omit If time was captured in CRFs, include in tabulations data Similar issue even when hour and minutes are captured (assumes seconds of :00 and triggers the error

6. Traceability No traceability between source data and datasets Need linkage: CRF -> SDTM -> ADaM -> CSR SDTM datasets should be created from CRFs If instead CRFs -> Raw -> SDTM, your analysis (and hopefully ADaM) datasets should be created from those same SDTM datasets, not the raw datasets Features exist in the ADaM standard that allow for traceability of analyses to ADaM to SDTM

6. Traceability CRF Creating SDTM and Analysis data from the raw data is incorrect (especially when submitting only SDTM and analysis data Raw data should create SDTM, and SDTM should then create Analysis Raw Data Analysis SDTM

7. Inadequate Documentation Often times not all aspects of the standard apply to your study/submission Submit supporting documentation in the form of a Reviewer s Guide to explain how the data standard was implemented: What is in the custom domains? What is in the suppqual s? Insufficient codelists? Unfixable errors/warnings and why? Derivation of key analysis variables

Contact Information: Please send CDER questions to: edata@fda.hhs.gov. Please send CBER questions to: cber.cdisc@fda.hhs.gov URLs: Study Data Standards for Submission to CDER http://www.fda.gov/drugs/developmentapprovalprocess/formssubmissionrequire ments/electronicsubmissions/ucm248635.htm Study Data Standards for Submission to CBER http://www.fda.gov/biologicsbloodvaccines/developmentapprovalprocess/ucm209 137.htm Study Data Resources http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm